Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report)'s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $51.99, but opened at $53.65. Sandoz Group shares last traded at $53.36, with a volume of 5,968 shares traded.
Analyst Ratings Changes
Separately, Royal Bank Of Canada upgraded Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd.
Check Out Our Latest Stock Report on Sandoz Group
Sandoz Group Stock Performance
The company has a fifty day simple moving average of $46.19 and a two-hundred day simple moving average of $44.51. The company has a current ratio of 1.24, a quick ratio of 0.79 and a debt-to-equity ratio of 0.57.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
